Shaping the industry


PSI works to shape the industry by promoting good practice for pharmaceutical statisticians in the scientific literature [1, 2], by promoting the value of statistical insight in the development of medicines with our directory of consultants and by lobbying to increase statistical input in regulatory decisions [3].

 

Our regulatory committee reviews and comments on regulatory guidelines on behalf of industry statisticians. Our special interest groups and working parties are forums for statisticians to share experiences and form guidelines for good practice in their specific areas of expertise.

 
PSI is a member of EFSPI, the European federation of national pharmaceutical statistics bodies and participates through EFSPI in Europe-wide industry discussions.

If you wish to contribute to any of these activities, contact chair@psiweb.org.

Latest News


Show all news

EventsFuture Events


  • Statistical Issues in Regulatory Submissions: Learning from the MHRA experience. - Dates: 10 Jun, 2019

    Based on the MHRA experience from hundreds of scientific advice meetings with industry and contributions to CHMP scientific advice, this one-day course will provide valuable insights to the most talked about methodological challenges facing applicants.
  • PSI Journal Club: PhD Webinar - Dates: 15 – 15 May, 2019

    Our next journal club is the inaugural PhD webinar, where we will share 4 topics with you from 4 PhD students. Our format will be slightly changed, with each student presenting for 10 minutes, followed by 5 minutes of discussion.
Laegemiddelstyrelsen_UK_360x180_jobzonen-og-jobfinder

Leading Biostatistician with experience in Big Data and advanced analytics

read more...

Laegemiddelstyrelsen_UK_360x180_jobzonen-og-jobfinder

Biostatistician with experience in clinical drug development

read more...

Astrazeneca

Senior / Principal Statistician – Centralised Statistical Monitoring (CSM)

read more...

bayerlogoresized

Statistician Opportunities in the UK

read more...